← 返回

细胞外囊泡来源 lncRNA 与 circRNA 在肿瘤及间充质干细胞中的新兴作用:生物学功能与临床应用潜力

英文原题:The Emerging Role of Extracellular Vesicle-Derived lncRNAs and circRNAs in Tumor and Mesenchymal Stem Cells: The Biological Functions and Potential for Clinical Application.

查看英文原题

The Emerging Role of Extracellular Vesicle-Derived lncRNAs and circRNAs in Tumor and Mesenchymal Stem Cells: The Biological Functions and Potential for Clinical Application.

PubMed 2025/06/28(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

细胞外囊泡(EVs)几乎由所有类型的细胞释放,它们通过运输生物活性分子(包括蛋白质、DNA、RNA和脂质)在细胞间进行通讯。近年来,EVs携带的RNA,特别是长链非编码RNA(lncRNA)和环状RNA(circRNA)亚型,在控制肿瘤进展方面的作用引起了人们的兴趣。其中,越来越多的报道称间充质干细胞来源的细胞外囊泡(MSC-EVs)维持着新发现的作为lncRNAs和circRNAs运输载体的功能。

然而,目前尚未对MSC-EVs中所含lncRNAs和circRNAs的详细分子功能进行总结,MSC-EVs作为分子载体的效力仍需进一步阐明。本综述总结了EVs的生物学特性以及其中所含lncRNAs和circRNAs的共同机制。重点阐述了EV来源的lncRNAs(EV-lncRNAs)和circRNAs(EV-circRNAs)在不同肿瘤类型与MSCs之间的“双刃剑”效应及相关分子机制。讨论了MSC-EVs在肿瘤诊断和治疗领域的潜力,为工程化MSC-EVs作为抗肿瘤药物载体的策略提出新方向。

展开英文摘要原文

Extracellular vesicles (EVs) are released by nearly all types of cells, and they communicate between cells by transporting bioactive molecules, including proteins, DNA, RNA, and lipids. In recent years, RNA carried by EVs, particularly the long-chain non-coding RNA (lncRNA) and circular RNA (circRNA) subtypes, has garnered interest with respect to their role in controlling tumor progression.

Among them, there are increasing reports that mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) maintain a recently discovered function as transporters of lncRNAs and circRNAs.

However, detailed molecular functions of lncRNAs and circRNAs contained in MSC-EVs are not presently summarized, and the efficacy of MSC-EVs as molecular carriers requires further elucidation. This review summarizes the biological characteristics of EVs and the common mechanisms of lncRNAs and circRNAs contained within them.

The "double-edged sword" effect and related molecular mechanism of EV-derived lncRNAs (EV-lncRNAs) and circRNAs (EV-circRNAs) between differing tumor types and MSCs are highlighted. The potential of MSC-EVs in the field of tumor diagnosis and treatment is discussed to suggest new directions for the strategy of engineering MSC-EVs as anti-tumor drug carriers.

论文信息

作者
Luo YW、Liu CG、Kirby JA、Chu C、Zang D、Chen J
单位
Department of Oncology, The Second Hospital of Dalian Medical University, Dalian 116021, China.China
文献类型
综述
期刊
Cancers2025 Jun 28
原文标识
PubMed 40647484 · DOI 10.3390/cancers17132186